07.04.2014 Views

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Hospital Length of Stay, Patient Reported Outcomes and 30-day Readmission Rates in Heart<br />

Failure Patients Receiving Osteopathic Manipulation.<br />

Otmaskin, E, OMS III; Carroll, B, OMS III; O’Toole, J, OMS IV; Smithson, S, OMS IV; Palermo, N,<br />

D.O.; Welch, R, OMS III; Cloutier, K, OMS III; Dombrowski, J, OMS III; Buan, S, OMS III; Guenette,<br />

C, OMS III; Doyle, R, OMS III.<br />

Manchester Memorial Hospital of Eastern Connecticut Health Network (ECHN) & University of New<br />

England College of Osteopathic Medicine (UNECOM), Department of Medical Education,<br />

Manchester, CT.<br />

Introduction: There are nearly 5 million people living with heart failure in the United States,<br />

accounting for over 1 million hospitalizations per year. There are also 550,000 new cases of HF<br />

diagnosed each year. Heart failure is the most common cause of hospital admissions in the United<br />

States and unsurprisingly, this clinical syndrome is extremely costly and places an increasingly<br />

enormous strain on our healthcare system and can severely lower a patient’s quality of life. Heart<br />

failure as a diagnosis carries a 50% 5 year survival rate. Heart failure is one of the leading causes<br />

for readmission 30 days post-discharge among Medicare Beneficiaries. Along with COPD and<br />

psychosis, HF readmissions accounted for $17.4 billion in 2004. It is in the best interest of hospital<br />

administrators, health care providers, and patients to maximize patient quality of life, minimize<br />

hospital length of stay and readmission for people with this chronic condition. The purpose of this<br />

study is to improve the standard of care for hospitalized heart failure patients. Our hypothesis is that<br />

Osteopathic Manipulation as an adjunct to the standard of care will improve patient outcomes as<br />

measured by Length of Stay, Readmission Rate, and Quality of Life compared to patient outcomes<br />

in those who receive the standard of care only.<br />

Methods: Patients admitted to MMH with a primary diagnosis of HF or HF exacerbation who meet<br />

clinical criteria (both inclusion and exclusion) and provide consent will be randomly placed in 1 of 3<br />

treatment groups: a treatment, a control, or a sham group. All groups will receive standard of care<br />

treatment. In addition to this, one group will receive no additional treatment, one group will receive<br />

an OMM protocol, and one group will receive a sham (placebo) protocol. All participants will<br />

complete a satisfaction survey upon discharge. Patient satisfaction, length of stay, and fluid balance<br />

and weight change will be recorded and compared among the 3 groups. Once sufficient participants<br />

have been recruited, a power analysis will be performed. A two-sample t-test will be used to<br />

examine if there is a significant difference in terms of the length of stay between the study groups.<br />

A two-sample proportion test will be used to examine if there is a significant difference in 30-day<br />

readmission rates among the study groups.<br />

Results: Since IRC approval, the study has 15 patients, and statistical analysis has been done on<br />

13 participants. Following the removal of 4 patients due to prolonged hospital stay and failure to<br />

complete the discharge questionnaire adjusted analysis was completed on 9 patients. The Adjusted<br />

Average Length of Stay: Sham Group 10.75 days (4 patients), Treatment Group 3.5 days (2<br />

patients), and Control Group 6.33 days (3 patients). Average Total Weight Change at End of Stay:<br />

Sham -4.08 kg, Treatment -4.73 kg, Control -4.82 kg. Average Fluid Balance at End of Stay: Sham<br />

-13.5 L, Treatment -3.0 L, Control -4.0 L. Change in average survey score: Sham +11, Treatment<br />

+3.75, Control -1.5. 30 Day Readmissions: Sham 0, Treatment 1, Control 1.<br />

Conclusion: This remains an ongoing research study. It received IRC reapproval in January of<br />

2013. Preliminary data has been analyzed, but remains inconclusive since the sample size has not<br />

met expectations. At the time of this submission, the strongest correlation has been increased<br />

patient satisfaction in the Treatment and Sham groups. Patient recruitment is actively underway,<br />

however the rate of new patient inclusion has fallen short of expectations due to difficulty obtaining<br />

a primary diagnosis of heart failure. Should this study demonstrate improved patient outcomes with<br />

the adjunct of Osteopathic Manipulation, the initiation of larger scale, longer term studies to further<br />

analyze this relationship would be warranted.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!